TREATMENT FOR ACUTE PAIN

NUCYNTA® (tapentadol), designed as a short-acting opioid, offers the same novel, active molecule as NUCYNTA® ER (tapentadol) extended-release tablets, CII. NUCYNTA is an opioid analgesic indicated for the management of moderate to severe acute pain in adults.1,2

Efficacy

See phase 3 data demonstrating the strength of NUCYNTA for patients with moderate to severe acute pain.

KNOW MORE
Safety and Tolerability

Learn about the well‑defined tolerability profile for NUCYNTA.

KNOW MORE
Dosing

Find out how to titrate to an optimal therapeutic dose.

KNOW MORE
References:
  1. Daniels SE, Upmalis D, Okamoto A, et al. A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr Med Res Opin. 2009;25:765-776.
  2. NUCYNTA® (package insert). Stoughton, MA: Collegium Pharmaceutical, Inc.; 2018.